🇺🇸 FDA
Patent

US 9649340

Methods for producing enriched populations of human retinal pigment epithelium cells

granted A61KA61K35/12A61K35/30

Quick answer

US patent 9649340 (Methods for producing enriched populations of human retinal pigment epithelium cells) held by Astellas Institute for Regenerative Medicine expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K35/12, A61K35/30, A61K35/44, A61K9/0048